Neumora News and Activities

Neumora is a company listed under the stock ticker NMR (US).

View the org chart displaying its 26 main executives

Most searched biographies at Neumora

• Paul Berns, Chairman of the Board and Chief Executive Officer
• David Piacquad, Director
• Maykin Ho, Director

Popular executive movements at Neumora

• David Phillips has joined the company as Senior Vice President of Quality  (posted on April 22 2026).

Create your alert
to follow the executive moves at Neumora.

Neumora has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Neumora

• Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder  - Neumora
• Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Neumora
• Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Neumora
• Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder  - Neumora
• Brain disease startup Neumora draws more funding for ambitious research plan
• Neumora Therapeutics Announces $112 Million Series B Financing - Neumora
• Neumora Therapeutics Announces $112 Million Series B Financing - Neumora
• Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases - Neumora
• Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases - Neumora
• Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University - Neumora
• View more press releases Close

Social media about Neumora

• Neumora on Wikipedia, Google News & Yahoo Finance
• Neumora on LinkedIn, X (Twitter) & YouTube